MMP‐19: cellular localization of a novel metalloproteinase within normal breast tissue and mammary gland tumours

Matrix metalloproteinases (MMPs) are instrumental in promoting and facilitating the spread of malignant diseases and in the de novo formation of blood vessels. This study has mapped the immunoreactivity of a novel, angiogenesis‐related metalloproteinase – MMP‐19 – in normal breast tissue and in benign and malignant breast lesions and compared this pattern of expression with that of MMP‐2. In the normal resting mammary gland, MMP‐19 was strongly expressed in the myoepithelial layer of the ductal system; the alveolar and ductal epithelia displayed considerable, but lobule‐specific, variations in labelling intensity. MMP‐19 was also present within the smooth muscle and endothelial layers of large and medium‐sized blood vessels, as well as within capillary walls. In benign lesions, all tumour cells and their surrounding vasculature were uniformly and strongly immunoreactive for MMP‐19. Progression towards an invasive phenotype and neoplastic dedifferentiation led to the disappearance of MMP‐19 from tumour cells and blood vessels and a concomitant rise in the levels of MMP‐2. In vitro experiments conducted with isolated smooth muscle cells cultivated on a solid substratum, or within the interstices of a collagen matrix, indicated that the expression of MMP‐19 is influenced by the architecture of the surrounding extracellular matrix. Copyright © 2001 John Wiley & Sons, Ltd.

[1]  P. Courtoy,et al.  The expression of interstitial collagenase in human endometrium is controlled by progesterone and by oestradiol and is related to menstruation. , 1995, The Biochemical journal.

[2]  G I Murray,et al.  Matrix metalloproteinases in tumour invasion and metastasis , 1999, The Journal of pathology.

[3]  D. Cheresh,et al.  Disruption of Angiogenesis by PEX, a Noncatalytic Metalloproteinase Fragment with Integrin Binding Activity , 1998, Cell.

[4]  T. Ny,et al.  Regulation and localization of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the mouse ovary during gonadotropin-induced ovulation. , 1999, Endocrinology.

[5]  U. Krawinkel,et al.  Matrix metalloproteinase-19 in capillary endothelial cells: expression in acutely, but not in chronically, inflamed synovium. , 1999, Experimental cell research.

[6]  L. Riethdorf,et al.  Matrix-metalloproteinases 1, 2 and 3 and their tissue inhibitors 1 and 2 in benign and malignant breast lesions: an in situ hybridization study , 1999, Virchows Archiv.

[7]  L. Coussens,et al.  Matrix metalloproteinases and the development of cancer. , 1996, Chemistry & biology.

[8]  R. Nicosia,et al.  Regulation of Vascular Growth and Regression by Matrix Metalloproteinases in the Rat Aorta Model of Angiogenesis , 2000, Laboratory Investigation.

[9]  Wen‐Tien Chen.  Membrane proteases: Roles in tissue remodeling and tumour invasion , 1992, Current Biology.

[10]  S. Curran,et al.  Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis. , 2000, European journal of cancer.

[11]  E. Ehler,et al.  Human foetal lung (IMR-90) cells: myofibroblasts with smooth muscle-like contractile properties. , 1996, Cell motility and the cytoskeleton.

[12]  Z. Shao,et al.  The human myoepithelial cell is a natural tumor suppressor. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[13]  D. Woolley,et al.  Matrix metalloproteinases in normal menstruation. , 1996, Human reproduction.

[14]  E. Hay,et al.  Epithelia suspended in collagen gels can lose polarity and express characteristics of migrating mesenchymal cells , 1982, The Journal of cell biology.

[15]  R. Sedláček,et al.  Structure of the human MMP-19 gene. , 2000, Gene.

[16]  A. Andres,et al.  Expression of stromelysin‐1 and timp‐1 in the involuting mammary gland and in early invasive tumors of the mouse , 1994, International journal of cancer.

[17]  U. Krawinkel,et al.  Matrix metalloproteinase MMP-19 (RASI-1) is expressed on the surface of activated peripheral blood mononuclear cells and is detected as an autoantigen in rheumatoid arthritis. , 1998, Immunobiology.

[18]  L. Liotta,et al.  Metalloproteinases and cancer invasion. , 1990, Seminars in cancer biology.

[19]  U. Krawinkel,et al.  The matrix metalloproteinase RASI-1 is expressed in synovial blood vessels of a rheumatoid arthritis patient. , 1997, Immunology letters.

[20]  C. López-Otín,et al.  Biochemical Characterization of the Catalytic Domain of Human Matrix Metalloproteinase 19 , 2000, The Journal of Biological Chemistry.

[21]  T. Ny,et al.  Regulation and Localization of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in the Mouse Ovary during Gonadotropin-Induced Ovulation1. , 1999, Endocrinology.

[22]  L Orci,et al.  Paracrine induction of angiogenesis in vitro by Swiss 3T3 fibroblasts. , 1993, Journal of cell science.

[23]  A. Draeger,et al.  Expression of smooth muscle markers in the developing murine lung: potential contractile properties and lineal descent , 1998, Histochemistry and Cell Biology.

[24]  J. Folkman,et al.  Regulation of Angiostatin Production by Matrix Metalloproteinase-2 in a Model of Concomitant Resistance* , 1999, The Journal of Biological Chemistry.

[25]  R. Sedláček,et al.  The murine ortholog of matrix metalloproteinase 19: its cloning, gene organization, and expression. , 2000, Gene.

[26]  P. D. Di Cesare,et al.  Matrix metalloproteinases 19 and 20 cleave aggrecan and cartilage oligomeric matrix protein (COMP) , 2000, FEBS letters.

[27]  U. Sauer,et al.  Tissue distribution of major matrix metalloproteinases and their transcripts in human breast carcinomas. , 1999, Anticancer research.